tiprankstipranks
Nanoveu Ltd. (AU:NVU)
ASX:NVU
Australian Market
Want to see AU:NVU full AI Analyst Report?

Nanoveu Ltd. (NVU) AI Stock Analysis

26 Followers

Top Page

AU:NVU

Nanoveu Ltd.

(Sydney:NVU)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$0.07
▼(-18.89% Downside)
Action:ReiteratedDate:03/02/26
The score is held down primarily by weak financial performance—deep losses, negative gross profit, and ongoing cash burn—despite relatively low recent leverage. Technicals are also soft (below key moving averages with negative MACD), with oversold indicators only partially offsetting. Valuation is constrained by a negative P/E, reflecting the lack of profitability.
Positive Factors
Low leverage / modest debt
Modest leverage reduces near-term solvency risk and gives the company more financial flexibility while it attempts to stabilize operations. A low-debt capital structure limits interest burden and lowers refinancing pressure, providing durable runway for commercialization and partner deals if cash burn is managed.
Negative Factors
Persistent negative cash flow
Chronic operating and free cash flow deficits mean the business consumes capital to run, forcing dependence on external funding. This structural cash burn raises dilution and liquidity risk, constrains investment in commercialization, and makes long-term plans contingent on securing reliable financing or rapid margin improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / modest debt
Modest leverage reduces near-term solvency risk and gives the company more financial flexibility while it attempts to stabilize operations. A low-debt capital structure limits interest burden and lowers refinancing pressure, providing durable runway for commercialization and partner deals if cash burn is managed.
Read all positive factors

Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)

Nanoveu Ltd. Business Overview & Revenue Model

Company Description
Nanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone scr...
How the Company Makes Money
Nanoveu makes money by commercializing its proprietary coating and film technologies through business-to-business arrangements, including supplying products and/or licensing its technology to partners that manufacture, distribute, or apply these c...

Nanoveu Ltd. Financial Statement Overview

Summary
Weak overall financial health: revenue has been volatile with a 2025 rebound, but profitability deteriorated sharply (negative gross profit and widening operating losses) and cash flow remains persistently negative. The balance sheet is a relative bright spot with low leverage in 2025, but ongoing losses make it sensitive to continued funding needs.
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue297.58K6.87K102.54K159.51K781.21K
Gross Profit-2.23M10.53K25.27K72.37K386.56K
EBITDA-7.45M-2.73M-1.98M-2.45M-1.97M
Net Income-7.42M-2.85M-2.16M-2.67M-2.32M
Balance Sheet
Total Assets13.55M1.32M513.00K427.33K2.75M
Cash, Cash Equivalents and Short-Term Investments1.81M498.30K73.07K248.14K2.01M
Total Debt341.96K126.33K225.26K300.00K986.68K
Total Liabilities1.46M983.58K622.40K700.75K1.17M
Stockholders Equity12.31M374.94K-109.41K-273.41K1.58M
Cash Flow
Free Cash Flow-5.92M-2.10M-2.01M-2.82M-2.04M
Operating Cash Flow-5.85M-2.10M-2.01M-2.82M-2.04M
Investing Cash Flow-287.31K-258.66K0.000.000.00
Financing Cash Flow7.44M2.53M1.83M142.12K2.91M

Nanoveu Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.09
Price Trends
50DMA
0.07
Positive
100DMA
0.08
Negative
200DMA
0.08
Negative
Market Momentum
MACD
<0.01
Negative
RSI
58.92
Neutral
STOCH
86.75
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NVU, the sentiment is Neutral. The current price of 0.09 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.07, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 58.92 is Neutral, neither overbought nor oversold. The STOCH value of 86.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NVU.

Nanoveu Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
48
Neutral
AU$30.75M-173.03-2.31%2.98%93.55%
48
Neutral
AU$19.00M-3.90-27.05%4.41%19.30%
48
Neutral
AU$26.41M-13.7646.05%-0.91%1.85%
43
Neutral
AU$76.71M-9.35-86.31%
43
Neutral
AU$1.75M-0.06-562.56%
41
Neutral
AU$18.61M-3.83-153.09%6.66%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NVU
Nanoveu Ltd.
0.07
0.03
82.05%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:VIG
Victor Group Holdings Ltd
0.04
-0.02
-33.87%
AU:AMX
Aerometrex Ltd.
0.20
-0.04
-18.37%
AU:XF1
Xref Ltd
0.12
0.00
0.00%
AU:ICE
iCetana Ltd.
0.04
0.02
133.33%

Nanoveu Ltd. Corporate Events

Nanoveu sets in-person May 29 AGM and shifts to digital meeting materials
Apr 28, 2026
Nanoveu Limited has called its Annual General Meeting for 11:00 a.m. AWST on 29 May 2026 at The Boorloo Meeting Room, 108 St Georges Terrace in Perth, with all resolutions to be decided by poll and shareholder eligibility determined as at 5:00 p.m...
Nanoveu sets 2026 AGM date and opens nominations for board candidates
Apr 9, 2026
Nanoveu Limited has scheduled its 2026 Annual General Meeting for 29 May 2026, with details to be provided in a forthcoming notice of meeting to shareholders. The company has set 17 April 2026 as the deadline for written nominations from individua...
Nanoveu Showcases EMASS Strategy at Pitt Street Semiconductor Conference
Mar 24, 2026
Nanoveu Limited announced its participation in the Pitt Street Research Semiconductor Conference 2026, where Director and EMASS founder Dr Mohamed Sabry is outlining the company&#8217;s strategy for advancing its EMASS semiconductor business. The ...
Nanoveu cancels 21 million unvested performance rights after conditions lapse
Mar 5, 2026
Nanoveu Limited has reported changes to its capital structure following the lapse of certain performance rights. According to the company&#8217;s notification, 21,000,000 performance rights, classified as NVUAI, have ceased on 27 February 2026 aft...
Nanoveu Director Alfred Chong Sees 5 Million Performance Rights Expire
Mar 5, 2026
Nanoveu Ltd. has reported a change in the interests of director Alfred Chong, reflecting the expiry of a substantial portion of his performance rights. The update, lodged with the ASX, outlines that 5,000,000 performance rights held by Chong have ...
Nanoveu files 2025 corporate governance statement with ASX
Feb 27, 2026
Nanoveu Limited has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 31 December 2025 is available on its website, in accordance with ASX Listing Rules. The statement, approved by the board, details t...
Nanoveu revenue surges but losses deepen in 2025 results
Feb 27, 2026
Nanoveu Limited reported a sharp increase in revenue from ordinary activities to A$298,000 for the year ended 31 December 2025, representing a 4,230% rise on the prior year. Despite this growth, the company&#8217;s net loss attributable to members...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 02, 2026